Artificial Intelligence 3D Augmented Reality Robot-Assisted-Radical- Prostatectomy v.s. no3D Intervention

Recruiting now · Not applicable

Conditions studied: Cancer of Prostate

In brief

This is a prospective randomized multicenter study aimed at comparing 3D AI-AR-RARP vs. no 3D, verifying the impact of this new technology on oncological and functional outcomes after the procedure.

Key facts

Study ID

NCT06318559

Run by

Fondazione del Piemonte per l'Oncologia

People needed

120

Starts

2022-06-29

Expected to finish

2027-12-31

Last updated by the study team

2024-03-19

Who can join

Age: 40 and older, up to 99. Sex: male. Healthy volunteers: not accepted.

You may qualify if…

• Signature of the written informed consent and consent to the use of personal data
• Age > 40 years and male sex
• Pre-operative MRI performed according to ESUR recommendations and reporting in accordance with PiRads V.2
• Disease with evidence of bulging or radiological T3 on pre-operative MRI
• Histological diagnosis of acinar type prostate cancer in the area highlighted on MRI
• Absence of bulky (>3 cm), bony or visceral retroperitoneal or pelvic lymph node metastatic lesions
• Patients eligible for radical prostatectomy + pelvic lymphadenectomy
• ECOG PS 0-1
• Life expectancy ≥ 5 years
• Patients motivated to preserve erection and with pre-operative sexual activity with IIEF >17
• Availability of the patient's pre-operative clinical data
• Patients must be available to carry out the visits foreseen in the follow-up of the protocol and consent to data collection

You may not qualify if…

• Special histotypes of prostate cancer
• Patients with PSA > 100 ng/ml at diagnosis
• Inability to perform MRI (pacemaker wearers, claustrophobia...) or MRI of inadequate quality to obtain the HA3DTM 3D reconstruction
• Concomitant treatment with other antineoplastic drugs including investigational endocrine therapies
• Serious uncontrolled concomitant medical condition or disease including active, uncontrolled infections
• Patients with dementia or psychiatric illness that limit compliance with study requirements or that may prevent understanding and/or signing informed consent.

Where it is running

• Fondazione del Piemonte per l'Oncologia-IRCCS Candiolo — Candiolo, Turin, Italy (enrolling)
• AOU san Luigi Gonzaga — Orbassano, Turin, Italy (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.